Translumina

Translumina’s mission, 'Exploring Limitless Possibilities for Life,' has always been at the forefront of improving patients' well-being through the advancement of standard care practices. With over 𝟏𝟎 𝐲𝐞𝐚𝐫𝐬 𝐨𝐟 𝐒𝐚𝐟𝐞𝐭𝐲 𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 established for its devices, We as an organisation always tend to seek what’s beyond. Therefore, we are grateful to announce the recruitment of 350+ patients in our 𝐒𝐄𝐂𝐔𝐑𝐄 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐲, which is a prospective, multi-national, multi-Centre observational study across UK, Netherlands, Italy and India with the overall objective to analyse safety and efficacy of the proven 𝐕𝐈𝐕𝐎 𝐈𝐒𝐀𝐑 (Polymer-Free Sirolimus eluting coronary stent system) in patient prescribed a shorter duration of dual antiplatelet therapy. We are thankful for the support of the Study Committee, Prof Adnan Kastrati (Study Chairperson), Prof Azfar Zaman (Global Lead PI), Prof Giuseppe Tarantini MD, PhD (Global Co-PI) and all the participating investigators contributing to the success of this global project and safety management of the patients. hashtag #ExploringLimitlessPossibilities #PatientWellBeing #ClinicalExcellence #SafetyAndPerformance #VIVOISAR #GlobalCollaboration

𝐀𝐧𝐨𝐭𝐡𝐞𝐫 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝! Translumina takes pride to announce that Celebrity Observatory in France has enrolled > 500 patients in real world scenario. With the objective of providing state-of-the art technology #VIVOISAR with exhaustive clinical data, the observatory aims to enroll 3000 patients in 2 years prospectively with secondary objective to analyse patients prescribed with short duration of DAPT. We express gratitude to our Lead PI, Dr Thibault Lhermusier and all the participating investigators across France in contributing towards the success of this project. Looking forward to celebrating many more achievements and successes of this global project. #TransluminaMilestones #ClinicalExcellence #RealWorldEvidence #VIVOISAR #HealthcareInnovation #GlobalHealthcare #PatientCentricCare

Amsterdam CTO was a great success Live cases with Protégé DCB, performed by Dr. Alex Nap & Dr. Yoshihisa Kinoshita, taking DCB technology to a new high! #Translumina #AmsterdamCTO2024 #ProtégéDCB #limitlesspossibilities Yoshihisa Kinoshita Angiocare Protégé Drug Coated Balloon

A decade of data. Millions of Smiling Families. VIVO ISAR - a polymer-free, sirolimus-eluting stent - has proven itself as a safe, durable, and effective solution for patients, with results published in leading journals across multiple studies. Explore the future of stent technology with VIVO ISAR - engineered for superior patient outcomes over the long term. #GoPolymerFree #SirolimusElutingStent #PolymerFreeStent #VivoIsar #TransluminaTherapeutics #Tranlumina #ExploringLimitlessPossibilities #LimitlessPossibilities

#GoPolymerFree with VIVO ISAR – a polymer-free drug eluting stent backed by a decade of data and designed for optimal performance. Combining sirolimus and probucol, it reduces complications seen with polymers. Proven over 10 years, it delivers superior outcomes in diabetic and ACS patients, paving the way for a future beyond polymers. #VivoIsar #DrugElutingStent #Translumina #TransluminaTherapeutics #LimitlessPossibilities

𝟐 𝐃𝐚𝐲𝐬 𝐭𝐨 𝐠𝐨! Join us at GIS Annual Conference 2024 on 28th-30th November. Meet our team and connect with global experts for insightful days into the future of cardiovascular innovation. We are excited to welcome you! #GIS2024 #CardiovascularInnovation #HealthcareExcellence #Translumina #GlobalExperts #MedicalDevices #PatientCare

II Only 2 Days Left II The Amsterdam CTO Symposium 2024 is happening in Amsterdam, Netherlands on 28th & 29th November. Meet our team and connect with global experts as we share insights into cardiovascular innovation. #AmsterdamCTO #InterventionalCardiology #LimitlessPossibilities #Translumina #ProtégéDCB

II Save the Date II GIS 2024 is just around the corner! 📍 Dubai, UAE 🗓 28th–30th Nov Meet team #Translumina and connect with global experts as we explore the forefront of cardiovascular innovation. #GIS2024 #Limitlesspossibilities #ProtégéDCB ##VIVOISAR

Interesting Highlights from the 26th Moscow International Congress on X-ray Endovascular Surgery Team Translumina participated alongside our trusted partner in Russia, Stentex, showcasing Translumina's innovative technologies. Together, we are exploring Limitless Possibilities! Stentex LLC #Translumina #Limitlesspossibilities #ProtégéDCB #VIVOISAR #MRC2024

Optima PCI 2024, Istanbul, was a great success✨ Prof. Sevket Gorgulu showcased live cases using Protégé DCB with successful kissing balloon technique and excellent results. The event featured engaging discussions and insightful meetings with Top KOLs reaffirming our commitment to taking DCB technology to a new high!!   #Translumina #limitlesspossibilities #OptimaPCI2024 #ProtégéDCB